h5n1 hpai and pandemic influenza
TRANSCRIPT
Departement Gesondheidswetenskappe •
Faculty of Health Sciences
Influenza viruses and influenza pandemics: virological and human aspects
Wolfgang Preiser
Discipline of Medical Virology, University of Stellenbosch; NHLS Tygerberg
Public Health Forum: How serious is the flu pandemic threat?Faculty of Health Sciences, Tygerberg Hospital
30th November 2005
15 HA types: H1 - H15
9 NA types: H1 - H9
–ssRNA in 8 segments
Hydrolysis of sialic acid
Receptor binding to sialic acid(N-acetyl-neuraminic acid)
Neuraminidase
Release of newly synthesised virions
Haemagglutinin
Antigenic drift ⇒ annual seasonal epidemicsH3N2 strain
Recommended composition of influenza virus vaccines for use in the 2006 southern hemisphere influenza season — an A/New Caledonia/20/99(H1N1)-like virus;— an A/California/7/2004(H3N2)-like virus;— a B/Malaysia/2506/2004-like virus.
all causes
Influenza pandemic
non-infectious causes
infectious diseases
United States of AmericaAntigenic shift ⇒ sporadic pandemicssubtype strain
H1N1
PB2
PA
NA
NP
M
HA
NS
PB1
H1N1
PB2
PA
NA
NP
M
HA
NS
PB1
8 segments
"Spanish"1918: 40 mio.
H2N2
PB2
PA
NA
NP
M
HA
NS
PB1
H2N2
PB2
PA
NA
NP
M
HA
NS
PB1
3 segments
"Asian"1957: 1 mio.
5 seg.
H3N2
"Hongkong"1968: 1 mio.
2 segments
H3N?
PB2
PA
NA
NP
M
HA
NS
PB1
H3N2
PB2
PA
NA
NP
M
HA
NS
PB1
6 seg.
1950
"Russian"1977:
lab isolate?
H1N1
mammalian influenza A virus
avian influenza A virus
α(2,6)
α(2,3)
"mixing vessel": α(2,6) und α(2,3)Reassortment ⇐
α(2,3), α(2,6): binding between sialic acid and galactoseAmino acids at positions 226 / 228 of HA: leucin / serin ⇒ α(2,6); glutamin / glycin ⇒ α(2,3)
Prerequisites for an influenza pandemic
1. new viral subtype ⇒ no population immunity
2. high pathogenicity and virulence for humans
3. efficient human-to-humantransmission
Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO
25 November 2005
Country Total cases * DeathsViet Nam 93 42Thailand 21 13Cambodia 4 4Indonesia 11 7China 3 2Total 132 68
* Total number of cases includes number of deaths.WHO reports only laboratory-confirmed cases.
Reasons for concern
2. highly pathogenic H5 and H7 types:several basic amino acids before HA cleavage site into HA1 and HA2 ⇒ ↑ tissue tropism ⇒ ↑ virulence
142 of 242 human infections with avian influenza viruses since 1959, and all but 1 of 70 human deaths,were due to H5N1!
1. new viral subtype ⇒ no population immunity
2. high pathogenicity and virulence for humans
3. efficient human-to-humantransmission
√
√
X
Prerequisites for an influenza pandemic
WHO global influenza preparedness plan
Interpandemic periodPhase 1: No new influenza virus subtypes in humansPhase 2: circulating animal influenza virus subtype poses a
substantial risk of human diseasePandemic alert periodPhase 3: human infection(s) with a new subtype, but no human-to-
human spread, or at most rare instances of spread to a close contact.
Phase 4: small cluster(s) with limited human-to-human transmission but spread highly localized (virus not well adapted to humans)
Phase 5: larger cluster(s) but human-to-human spread still localized (virus becoming increasingly better adapted to humans)
Pandemic periodPhase 6: pandemic: increased and sustained transmission in general
population
WHO Department of Communicable Disease Surveillance and Response –Global Influenza Programme
WHO global influenza preparedness plan
Interpandemic periodPhase 1: No new influenza virus subtypes in humansPhase 2: circulating animal influenza virus subtype poses a
substantial risk of human diseasePandemic alert periodPhase 3: human infection(s) with a new subtype, but no human-to-
human spread, or at most rare instances of spread to a close contact.
Phase 4: small cluster(s) with limited human-to-human transmission but spread highly localized (virus not well adapted to humans)
Phase 5: larger cluster(s) but human-to-human spread still localized (virus becoming increasingly better adapted to humans)
Pandemic periodPhase 6: pandemic: increased and sustained transmission in general
population
WHO Department of Communicable Disease Surveillance and Response –Global Influenza Programme
WHO Epidemic and Pandemic Alert and Response (EPR) – 14 October 2005
1. Pandemic influenza is different from avian influenza2. Influenza pandemics are recurring events3. The world may be on the brink of another pandemic4. All countries will be affected5. Widespread illness will occur6. Medical supplies will be inadequate7. Large numbers of deaths will occur8. Economic and social disruption will be great9. Every country must be prepared10. WHO will alert the world when the pandemic
threat increases